-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Tenaya Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2024.
- Tenaya Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$28.7M, a 5.38% increase year-over-year.
- Tenaya Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$102M, a 2.25% increase from 2022.
- Tenaya Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$104M, a 71.7% decline from 2021.
- Tenaya Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$60.8M, a 71.6% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)